课题基金 / 基金详情

项目摘要

项目成果

Kevin V Morris的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Targeted inhibition of HIV-1 latency Summary Human Immunodeficiency Virus type 1 (HIV) ravages the immune system of infected individuals by prolonged latent infection of immune cells. An understanding of the molecular mechanisms regulating latency could lead to strategies aimed at either inhibiting this process and purging cellular reservoirs of HIV. We have learned that an HIV expressed antisense long non-coding RNA (lncRNA) functions in epigenetically modulating viral transcription. In this project we propose to mechanistically validate the role of this lncRNA in driving viral latency, determine what host proteins are involved in the process, and develop an innovative strategy to treat cells such that the virus cannot enter latency. The completion of this project will significantly expand our current understanding of HIV infection and provide new avenues to modulate viral expression that may prove relevant in both therapeutic strategies to purge viral reservoirs as well as possible approaches to develop an HIV vaccine.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
In the first post-genomic decade, the ENCODE and FANTOM consortia have revolutionized. Introduction.
在后基因组的第一个十年中,ENCODE 和 FANTOM 联盟发生了革命性的变化。
DOI: --
发表时间: 2016
期刊: Current topics in microbiology and immunology
影响因子: --
作者: [Morris,KevinV]
通讯作者: Morris,KevinV
DOI: 10.3389/fgene.2016.00026
发表时间: 2016
期刊: Frontiers in genetics
影响因子: 3.7
作者: [Milligan MJ, Harvey E, Yu A, Morgan AL, Smith DL, Zhang E, Berengut J, Sivananthan J, Subramaniam R, Skoric A, Collins S, Damski C, Morris KV, Lipovich L]
通讯作者: Lipovich L
Targeted transcriptional activation of HIV
Activating cystic fibrosis transmembrane conductance regulator: the therapeutic potential of RNA directed gene activation
Activating cystic fibrosis transmembrance conductance regulator: the therapeutic potential of RNA directed gene activation
  • 批准号:
    8855170
  • 项目类别:
  • 资助金额:
    $41.37万
  • 财政年份:
    2015
  • 负责人:
    Kevin V Morris
  • 依托单位:
Targeted inhibition of HIV-1 latency
  • 批准号:
    8895833
  • 项目类别:
  • 资助金额:
    $55.62万
  • 财政年份:
    2014
  • 负责人:
    Kevin V Morris
  • 依托单位:
海外基金